Category: Disclosures

[Disclosure] ISU PETASYS (007660) – Paid-in Capital Increase (Correction) / 2024-12-11

December 11, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS has postponed its rights offering schedule by approximately one month, moving the record date to January 20, 2025, the existing shareholder subscription to February 24–25, 2025, and the payment date to March 5, 2025. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment…

Semiconductors, Disclosures

[Disclosure] ISU PETASYS (007660) – Setting of Record Date or Closing Period of Shareholder Register (Correction) / 2024-12-11

December 11, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS has amended its record date for determining shareholders entitled to new share allocations under its rights offering from December 17, 2024, to January 20, 2025, due to changes in the offering schedule. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up…

Semiconductors, Disclosures

[Disclosure] Hanwha Ocean (042660) – Decision on Debt Guarantee for Others / 2024-12-10

December 10, 2024August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Ocean has decided to provide a performance guarantee worth KRW 115.2B (guarantee limit: USD 80,397,329.20) for a vessel being built by Philly Shipyard Inc., an entity scheduled for acquisition by its affiliate (Hanwha Ocean USA International LLC). 📊 [Key Disclosure Details & Financial Highlights] 📝…

Disclosures, Shipbuilding

[Disclosure] Hyundai Motor (005380) – Suspension of Production / 2024-12-05

December 5, 2024August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor temporarily suspended operations across all business sites, including the Ulsan Plant, affecting automobile manufacturing, maintenance, and sales on December 5 and 6, 2024 (2 hours per shift), due to a partial strike associated with KCTU’s general strike. 📊 [Key Disclosure Contents & Major Figures…

Disclosures, Automotive

[Disclosure] Celltrion (068270) – Decision on Retirement of Shares / 2024-12-04

December 4, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion decided to retire 3,011,910 previously acquired treasury common shares (valued at approx. KRW 491.8 billion) on January 6, 2025, to stabilize its stock price and enhance shareholder value. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Share…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-12-03

December 3, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has signed a contract worth approximately KRW 204.6B with the Defense Acquisition Program Administration for Chunma Performance-Based Logistics (PBL). 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Contract Performance Progress and Financial Reflection This long-term logistics support contract…

Disclosures, Defense

[Disclosure] ISU PETASYS (007660) – Clarification on Rumors or News Reports (Unconfirmed) / 2024-12-03

December 3, 2024August 1, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS clarified that nothing has been finalized regarding news reports about abandoning its acquisition of JEIO, stating that a follow-up disclosure will be made once details are confirmed or within one month. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Semiconductors, Disclosures

[Disclosure] Celltrion (068270) – Submission of Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in the US / 2024-12-02

December 2, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion submitted an application for a Phase 3 Clinical Trial Plan to the US FDA for CT-P44, a biosimilar referencing Darzalex, targeting patients with refractory or relapsed multiple myeloma. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring US FDA…

Disclosures, Bio & Healthcare

[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-12-02

December 2, 2024August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor recorded total global sales of 355,729 units in November 2024 (-3.7% YoY), bringing its cumulative sales from January to November 2024 to 3,809,424 units (-1.7% YoY). 📊 [Key Disclosure Contents & Major Figures Summary] 1. Monthly Sales Performance for November 2024 (Unit: Vehicles, %)…

Disclosures, Automotive

[Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2024-12-02

December 2, 2024August 12, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor will hold an IR conference for major overseas institutional investors from December 4 to December 5, 2024, at Grand Hyatt Tokyo, Japan, sponsored by Nomura Securities to present its Q3 2024 business performance. 📊 [Key Disclosure Contents & Major Figures Summary] 📝 Editor’s Comment…

Disclosures, Automotive